Vitamin D levels among patients with colorectal cancer (CRC) from the San Francisco Bay area. Read more about Vitamin D levels among patients with colorectal cancer (CRC) from the San Francisco Bay area.
Referral patterns among patients with metastatic breast cancer in an integrated palliative care program. Read more about Referral patterns among patients with metastatic breast cancer in an integrated palliative care program.
Genomic profiling to distinguish poorly differentiated neuroendocrine carcinomas arising in different sites. Read more about Genomic profiling to distinguish poorly differentiated neuroendocrine carcinomas arising in different sites.
Association between T cell repertoire diversification and both clinical response as well as toxicity following immune checkpoint blockade in metastatic cancer patients. Read more about Association between T cell repertoire diversification and both clinical response as well as toxicity following immune checkpoint blockade in metastatic cancer patients.
Addition of pazopanib (PZ) to endocrine therapy in hormone resistant advanced breast cancer (ABC). Read more about Addition of pazopanib (PZ) to endocrine therapy in hormone resistant advanced breast cancer (ABC).
Phase I investigation of lenalidomide plus rituximab and outcomes of lenalidomide maintenance in recurrent CNS lymphoma. Read more about Phase I investigation of lenalidomide plus rituximab and outcomes of lenalidomide maintenance in recurrent CNS lymphoma.
Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia. Read more about Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia.
Women informed to screen depending on measures of risk (WISDOM): A RCT of personalized vs. annual screening for breast cancer. Read more about Women informed to screen depending on measures of risk (WISDOM): A RCT of personalized vs. annual screening for breast cancer.
The WISDOM study pilot: Evaluating a preference-tolerant RCT of risk-based vs. annual breast cancer screening. Read more about The WISDOM study pilot: Evaluating a preference-tolerant RCT of risk-based vs. annual breast cancer screening.
Improving venous thromboembolism (VTE) prophylaxis for hospitalized malignant hematology/bone marrow transplant (heme/BMT) patients. Read more about Improving venous thromboembolism (VTE) prophylaxis for hospitalized malignant hematology/bone marrow transplant (heme/BMT) patients.
